Authors:
KE HZ
SHEN VW
QI H
CRAWFORD DT
WU DD
LIANG XG
CHIDSEYFRINK KL
PIRIE CM
SIMMONS HA
THOMPSON DD
Citation: Hz. Ke et al., PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Bone (New York, N.Y.), 23(3), 1998, pp. 249-255
Citation: Ha. Simmons et al., PARATHYROID-HORMONE-(1-34) INCREASED TOTAL-BODY BONE MASS IN AGED FEMALE RATS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 341-344
Authors:
ROSATI RL
JARDINE PD
CAMERON KO
THOMPSON DD
KE HZ
TOLER SM
BROWN TA
PAN LC
EBBINGHAUS CF
REINHOLD AR
ELLIOTT NC
NEWHOUSE BN
TJOA CM
SWEETNAM PM
COLE MJ
ARRIOLA MW
GAUTHIER JW
CRAWFORD DT
NICKERSON DF
PIRIE CM
QI H
SIMMONS HA
TKALCEVIC GT
Citation: Rl. Rosati et al., DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/, Journal of medicinal chemistry, 41(16), 1998, pp. 2928-2931
Authors:
KE HZ
PARALKAR VM
GRASSER WA
CRAWFORD DT
QI H
SIMMONS HA
PIRIE CM
CHIDSEYFRINK KL
OWEN TA
SMOCK SL
CHEN HK
JEE WSS
CAMERON KO
ROSATI RL
BROWN TA
DASILVAJARDINE P
THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/, Endocrinology, 139(4), 1998, pp. 2068-2076
Authors:
KE HZ
CHEN HK
SIMMONS HA
QI H
CRAWFORD DT
PIRIE CM
CHIDSEYFRINK KL
MA YF
JEE WSS
THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL, Bone, 20(1), 1997, pp. 31-39
Authors:
PARALKAR VM
GRASSER WA
OWEN TA
VAIL AL
PIRIE CM
THOMPSON DD
Citation: Vm. Paralkar et al., 5-FLUOROURACIL TREATMENT OF RAT BONE-MARROW CELLS PRODUCES A POPULATION OF STEM-CELLS THAT CAN RESPOND TO PROSTAGLANDINE(2) (PGE(2)) AND DIFFERENTIATE TO THE OSTEOBLASTIC LINEAGES, Journal of bone and mineral research, 12, 1997, pp. 339-339
Authors:
CRAWFORD DT
CHIDSEYFRINK KL
QI H
PIRIE CM
KE HZ
THOMPSON DD
Citation: Dt. Crawford et al., CP-336,156 PROTECTS AGAINST CANCELLOUS AND CORTICAL BONE LOSS IN OVARIECTOMIZED RATS - A PERIPHERAL QUANTITATIVE COMPUTED-TOMOGRAPHY (PQCT)STUDY, Journal of bone and mineral research, 12, 1997, pp. 488-488
Authors:
KE HZ
CHIDSEYFRINK KL
QI H
CRAWFORD DT
PIRIE CM
SIMMONS HA
THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Journal of bone and mineral research, 12, 1997, pp. 494-494
Authors:
LIANG XG
CRAWFORD DT
CHIDSEYFRINK KL
PIRIE CM
SIMMONS HA
THOMPSON DD
SHEN V
KE HZ
Citation: Xg. Liang et al., PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS, Journal of bone and mineral research, 12, 1997, pp. 495-495
Authors:
GRASSER WA
OWEN TA
MANSOLF AL
PIRIE CM
THOMPSON DD
PARALKAR VM
Citation: Wa. Grasser et al., 5-FLUOROURACIL TREATMENT OF RAT BONE-MARROW CELLS PRODUCES A POPULATION OF STEM-CELLS THAT CAN DIFFERENTIATE TO THE OSTEOBLASTIC AND OSTEOCLASTIC LINEAGES, Molecular biology of the cell, 7, 1996, pp. 3389-3389
Authors:
THOMPSON DD
OI H
CRAWFORD DT
PIRIE CM
SIMMONS HA
KE HZ
Citation: Dd. Thompson et al., DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS, Journal of bone and mineral research, 11, 1996, pp. 1-1
Authors:
KE HZ
CRAWFORD DT
OI H
CHIDSEYFRINK KL
SIMMONS HA
PIRIE CM
CHEN HK
JEE WSS
ROSATI RL
CAMERON KO
TOLER SM
JARDINE PD
THOMPSON DD
Citation: Hz. Ke et al., CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/, Journal of bone and mineral research, 11, 1996, pp. 251-251
Authors:
GRASSER WA
MANSOLI AL
PIRIE CM
CAMERON KO
TOLER SM
ROSATI RL
BROWN TA
DASILVAJARDINE P
THOMPSON DD
PARALKAR VM
Citation: Wa. Grasser et al., CP-336,156 AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RATBONE-MARROW CULTURES THROUGH AN APOPTOTIC MECHANISM, Journal of bone and mineral research, 11, 1996, pp. 392-392
Authors:
KE HZ
CHEN HK
QI H
PIRIE CM
SIMMONS HA
MA YF
JEE WSS
THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF DROLOXIFENE ON PREVENTION OF CANCELLOUS BONE LOSS AND BONETURNOVER IN THE AXIAL SKELETON OF AGED, OVARIECTOMIZED RATS, Bone, 17(5), 1995, pp. 491-496
Authors:
CHEN HK
KE HZ
JEE WSS
MA YF
PIRIE CM
SIMMONS HA
THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE PREVENTS OVARIECTOMY-INDUCED BONE LOSS IN TIBIAE AND FEMORA OF AGED FEMALE RATS - A DUAL-ENERGY X-RAY ABSORPTIOMETRIC AND HISTOMORPHOMETRIC STUDY, Journal of bone and mineral research, 10(8), 1995, pp. 1256-1262
Authors:
KE HZ
CRAWFORD DT
SIMMONS HA
PIRIE CM
OI H
THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 10, 1995, pp. 143-143
Authors:
OI H
KE HZ
CRAWFORD DT
PIRIE CM
SIMMONS HA
THOMPSON DD
Citation: H. Oi et al., DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 198-198
Authors:
SIMMONS HA
PIRIE CM
GRASSER WA
THOMPSON DD
Citation: Ha. Simmons et al., BONE CELL-DYNAMICS FOLLOWING MARROW ABLATION AND THE ROLE OF PROSTAGLANDINS, Journal of bone and mineral research, 10, 1995, pp. 307-307
Authors:
GRASSER WA
PAN LC
SIMMONS HA
SMOCK SL
PIRIE CM
THOMPSON DD
Citation: Wa. Grasser et al., DROLOXIFENE AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RAT BONE-MARROW CULTURES, Journal of bone and mineral research, 10, 1995, pp. 323-323
Authors:
CHEN HK
KE HZ
LIN CH
MA YF",OI,"QI H
CRAWFORD DT
SIMMONS HA
PIRIE CM
JEE WSS
THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Journal of bone and mineral research, 10, 1995, pp. 355-355
Authors:
KE HZ
SIMMONS HA
PIRIE CM
CRAWFORD DT
THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS, Endocrinology, 136(6), 1995, pp. 2435-2441
Citation: Dd. Thompson et al., DIFFERENTIAL RESPONSE OF BONE FROM OVARIECTOMIZED RATS TO VARYING DELIVERY REGIMENS AND DOSES OF ESTROGEN, Journal of bone and mineral research, 8, 1993, pp. 190000272-190000272
Citation: Ha. Simmons et al., RAPID ACTIVATION OF BONE TURNOVER PRODUCES PROGRESSIVE TRABECULAR THINNING AND OSTEOPENIA IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 8, 1993, pp. 190000272-190000272